Market Impact: Vaccine Stocks Tumble Following Trump's RFK Jr. HHS Nomination
Pharmaceutical stocks experienced significant declines after President-elect Trump named Robert F. Kennedy Jr. as his choice to lead the Department of Health and Human Services. Major vaccine manufacturers including Pfizer, Moderna, and European counterparts saw their shares drop as markets responded to the appointment of Kennedy, known for his critical stance on vaccines and pharmaceutical industry practices.